These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 23499593

  • 1. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.
    Vaccine; 2013 Apr 26; 31(18):2302-9. PubMed ID: 23499593
    [Abstract] [Full Text] [Related]

  • 2. Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine.
    Barrette RW, Szczepanek SM, Rood D, Challa S, Avery N, Vajdy M, Kramer E, Rodriguez L, Silbart LK.
    Clin Vaccine Immunol; 2011 Nov 26; 18(11):1996-8. PubMed ID: 21918121
    [Abstract] [Full Text] [Related]

  • 3. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 4. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 5. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 6. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.
    Virology; 2017 Feb 25; 502():123-132. PubMed ID: 28039799
    [Abstract] [Full Text] [Related]

  • 9. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
    Moraes MP, Chinsangaram J, Brum MC, Grubman MJ.
    Vaccine; 2003 Dec 12; 22(2):268-79. PubMed ID: 14615155
    [Abstract] [Full Text] [Related]

  • 10. Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.
    Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Salazar AM, Grubman MJ, de Los Santos T.
    Virology; 2014 Nov 12; 468-470():283-292. PubMed ID: 25216089
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA.
    BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, Wang B.
    Vaccine; 2008 Sep 19; 26(40):5135-44. PubMed ID: 18462848
    [Abstract] [Full Text] [Related]

  • 13. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ.
    Vaccine; 2008 Oct 23; 26(45):5689-99. PubMed ID: 18762225
    [Abstract] [Full Text] [Related]

  • 14. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
    Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los Santos T, Szczepanek SM.
    Vaccine; 2019 Jun 06; 37(26):3435-3442. PubMed ID: 31085001
    [Abstract] [Full Text] [Related]

  • 15. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
    de Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, Golde WT, Grubman MJ.
    Vaccine; 2006 Apr 24; 24(17):3446-56. PubMed ID: 16522345
    [Abstract] [Full Text] [Related]

  • 16. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP, Mayr GA, Mason PW, Grubman MJ.
    Vaccine; 2002 Feb 22; 20(11-12):1631-9. PubMed ID: 11858872
    [Abstract] [Full Text] [Related]

  • 17. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q, Moraes MP, Grubman MJ.
    Virus Res; 2003 Jun 22; 93(2):211-9. PubMed ID: 12782369
    [Abstract] [Full Text] [Related]

  • 18. Intranasal delivery of a recombinant adenovirus vaccine encoding the PEDV COE elicits potent mucosal and systemic antibody responses in mice.
    Yan S, Luo Y, Zhan N, Xu H, Yao Y, Liu X, Dong X, Kang L, Zhang G, Liu P.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0069224. PubMed ID: 39145626
    [Abstract] [Full Text] [Related]

  • 19. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B, Blanco E, Rodríguez Pulido M, Mateos F, Lorenzo G, Cardillo S, Smitsaart E, Sobrino F, Sáiz M.
    Antiviral Res; 2017 Jun 03; 142():30-36. PubMed ID: 28315707
    [Abstract] [Full Text] [Related]

  • 20. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G, Wang H, Wang F, Yu L.
    Res Vet Sci; 2013 Jun 03; 94(3):796-802. PubMed ID: 23267820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.